Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EndoShape was a U.S.-based medical device company developing minimally invasive embolization and occlusion devices for peripheral vascular, non-vascular, and neurovascular applications. Its technology centered on radiopaque shape-memory biocompatible polymers designed to improve upon conventional metal-based embolization approaches. The company was particularly associated with the coil embolization and occlusion market and with its Medusa MultiCoil device. Available secondary sources indicate that EndoShape raised venture financing but does not appear to have achieved broad commercial scale, and more recent databases suggest the company is no longer active. Overall, EndoShape appears to have been an early-stage interventional radiology/device developer rather than a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EndoShape.